XTL Biopharmaceuticals Ltd. (TLV: XTLB)

XTL Biopharmaceuticals Market Cap

XTL Biopharmaceuticals has a market cap or net worth of 80.28 million as of November 19, 2024. Its market cap has increased by 320.93% in one year.

• Market Cap: 80.28M
• Enterprise Value: 71.64M
• Revenue: n/a
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: 6.80

Market Cap Chart

Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 80.28M, a decrease of -90.03%. That is a compound annual growth rate of -11.30%.

Market Cap History

Date	Market Cap	% Change
Nov 18, 2024	84.04M	340.66%
Dec 31, 2023	19.07M	-14.63%
Dec 29, 2022	22.34M	-52.02%
Dec 30, 2021	46.56M	-7.60%
Dec 31, 2020	50.39M	108.51%
Dec 31, 2019	24.17M	-26.56%